Insulin-like growth factor-I regulates pro-B cell differentiation

Area of Science:

• Immunology
• Developmental Biology
• Hematopoiesis

Background:

• B-lymphocyte development involves immunoglobulin gene rearrangement and expression.
• Interleukin-7 (IL-7) and kit ligand (KL) stimulate pre-B cell proliferation but not early B-cell differentiation.
• Bone marrow stromal cells were previously shown to induce pro-B cell differentiation and immunoglobulin expression.

Purpose of the Study:

• To identify the specific factor(s) from bone marrow stromal cells responsible for pro-B cell differentiation and immunoglobulin expression.
• To elucidate the role of insulin-like growth factor-I (IGF-I) in early B-lymphopoiesis.

Main Methods:

• Utilized recombinant IGF-I and anti-IGF-I antibodies in short-term bone marrow cultures.
• Employed antisense oligonucleotides targeting IGF-I in stromal cell supernatants.
• Assessed cytoplasmic mu-heavy chain expression and pro-B cell differentiation.
• Evaluated the effect of IGF-I on IL-7-stimulated proliferation.

Main Results:

• Recombinant IGF-I stimulated cytoplasmic mu-heavy chain expression in pro-B cells.
• Anti-IGF-I antibody or IGF-I antisense oligonucleotides blocked the differentiation activity of stromal cell supernatants.
• IGF-I did not directly induce proliferation but potentiated the proliferative effects of IL-7.

Conclusions:

• Stromal cell-derived IGF-I is a key regulator of primary B lymphopoiesis.
• IGF-I promotes immunoglobulin gene expression and enhances IL-7-mediated proliferation in B-lymphoid cells.
• IGF-I plays a critical role in the hematopoietic microenvironment for B-cell development.